The medication itself does not act on the vulva, vagina, or pelvic floor, and the changes are really byproducts of body composition shifting quickly. When rapid weight loss occurs, fat pads in the vulva can shrink
Key factors include: Long and expensive medication development Complex peptide and injectable manufacturing Limited direct competition during patent protection Insurance and prior-authorization rules Deductibles, copays and coinsurance Rapidly growing demand Patients should compare current coverage, pharmacy prices, manufacturer programs and medically appropriate options with their healthcare provider
Moreover, there is an extension of this benefit for people with diabetes found in studies of those with obesity without T2D
What to keep in mind: TrimRx offers both GLP-1 (semaglutide) and GLP-1 + GIP (tirzepatide) options, giving you flexibility depending on what your clinician recommends
The pathogenesis of diabetes involves a defective amplification of the late phase insulin response to glucose by GIPregardless of aetiology and phenotype